Director Dealing-ALLIANCE PHARMA PLC

Director Dealing-ALLIANCE PHARMA PLC

Director Dealing

Alliance Pharma plc (AIM: APH), the international healthcare group, has been notified that Jo LeCouilliard, the non-executive Chair of the Company, purchased 40,957 ordinary shares of 1.0p each in the Company ("Ordinary Shares") at a price of 48.8 pence per share on 20th July 2023.

Following this transaction, (i) Jo LeCouilliard's total beneficial interest in the Company is 40,957 Ordinary Shares, representing 0.008% of the Company's issued share capital.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jo LeCouilliard

2

Reason for the notification

a)

Position/status

Non-executive Chair, PDMR

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Alliance Pharma Plc

b)

Legal Entity Identifier

213800RYIWZA4Q5WPZ13

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1 pence each

 

 

 

 

 

GB0031030819

 

b)

Nature of the transaction

Purchase of shares

c)

Currency

GBP

 

d)

Price(s) and volume(s)

Price(s)

Volume(s)

48.8

40,957

 

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

40,957 Ordinary Shares, bought at a price of 48.8 pence per share, totalling £ 19,987.02.

 

f)

Date of the transaction

20 July 2023

g)

Place of the transaction

London Stock Exchange, AIM

No Comments

Post a Comment